Cyclosporine A versus cyclosporine G: a comparative study of survival, hepatotoxicity, nephrotoxicity, and splenic atrophy in BALB/c mice

Transplant International - Tập 1 - Trang 13-18 - 1988
Marwan A. Masri1,2, Mohammed Naiem1,2, Shridevi Pingle1,2, Abdallah S. Daar1,2
1Emirates Institute for Medical Research, Mafraq Hospital, Abu Dhabi, United Arab Emirates
2Organ Transplant Unit, Mafraq Hospital, Abu Dhabi, United Arab Emirates

Tóm tắt

Our group has previously shown that cyclosporine A (CSA) but not cyclosporine G (CSG) causes splenic atrophy in a BALB/c mouse model. We have now extended our studies to observations of the effect of the two drugs on other parenchymal organs and on the nervous system. Groups of mice (N=30) were given 150 mg/kg per day of either CSA or CSG and were compared to two control groups. Absorption of the drugs was similar in the two groups, although CSG blood levels were slightly higher. Animals treated with CSA, but not CSG, lost up to 50% of body weight over a 3-week period. Overall mortality was much higher in the CSA group. Blood urea levels were significantly higher in both treatment groups than in controls and were significantly higher in the CSA than in the CSG group. CSA-treated animals showed marked histological changes in their kidneys, the most prominent of which was proximal tubular vacuolation. Both drugs showed some hepatotoxicity, both histologically and biochemically; the histological changes were more marked in the CSA group. There was no pancreatic toxicity at this dose, either histologically or in terms of blood-sugar concentrations. Mice treated with CSA, but not with CSG, showed marked behavioral changes, including hyperactivity and irritability. The most intriguing observation was the effect of CSA, but not CSG, on the spleen. There was atrophy of lymphoid tissue in both the B and the T cell areas, although the most prominent change was in the periarterial lymphatic sheaths. These changes may be of significance in the longterm maintenance of immunosuppression and graft acceptance. CSG appears, therefore, to be significantly less toxic overall in this model than CSA and warrants further study, both experimentally and clinically.

Tài liệu tham khảo

Belitsky P, Ghose T, Givner M, Rowdeng G, Pope B (1986) Tissue distribution of cyclosporine A in the mouse: a clue to toxicity. Clin Nephrol [Suppl 1] 25: S27-S29

Beschorner WE, Namnoum JD, Hess AD (1987) Immunopathology of rat thymus after cyclosporine A. Transplant Proc 19: 1230–1235

Blair JT, Thomson AW, Whiting PH, Davidson RJL, Simpson JG (1982) Toxicity of the immunosuppressant cyclosporine A in the rat. J Pathol 138: 163–178

Borel JF, Feurer C, Gubler HU, Stähelin H (1976) Biological effects of cyclosporine A: a new antilymphocytic agent. Agents Actions 6: 468–475

Calne RY, White DJG, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Pentlow DB, Rolles K (1979) Cyclosporine A in patients receiving renal allografts from cadaver donors. Lancet II: 1323–1327

Calne RY, White DJG, Thiru S, Rolles K, Drakopoulos S, Jamieson NV (1985) Cyclosporine G: immunosuppressive effect in dogs with renal allografts. Lancet I: 1342

Collier DStJ, Calne RY, White DJG, Winters S, Thiru S (1986) Blood levels and nephrotoxicity of cyclosporine A and G in rats. Lancet I: 216

Daar AS, Pingle S, Naiem M, Masri MA (1987) Histological changes in atrophic spleens of mice treated with cyclosporine A. Transplant Proc 19: 4329–4330

Duncan JI, Thomson AW, Aldridge RD, Simpson JG, Whiting PH (1986) Cyclosporine-induced renal structural damage: influence of dosage, strains, age and sex with reference to the rat and guinea pig. Clin Nephrol [Suppl 1] 25: S14-S17

Duncan JI, Thomson AW, Simpson JG, Davidson RJL, Whiting PH (1986) Comparative toxicological study of cyclosporine and Nva2-cyclosporine in Sprague-Dawley rats. Transplantation 42: 395–399

Hahn HJ, Laube F, Lucke S, Klotting I, Kohnert KD, Warzock R (1986) Toxic effects of cyclosporine on the endocrine pancreas of wistar rats. Transplantation 41: 44–47

Hiestand PC, Gunn HC, Gale JM, Ryffel B, Borel JF (1985) Comparison of the pharmacological profiles of cyclosporine (Nva2) cyclosporine and (Val 2) dihydrocyclosporine. Immunology 55: 249–255

Hiestand PC, Gunn HC, Gale JM, Siegl H, Ryffel B, Donatsch P, Borel JF (1985) The immunosuppressive profile of a new natural cyclosporine analogue: (Nva2) cyclosporine. Transplant Proc 17: 1362–1364

Hohn DC, Goldstones J (1985) Spleen. In: Way LW (ed) Current surgical diagnosis and treatment. Lange, Los Altos, Calif

Huser B, Landmann J, Mihatsch MJ, Bianchil L, Thiel G (1987) Clinical pilot study with cyclosporine G (CYG) in kidney transplant recipients. In: 3rd Congress of the European Society of Organ Transplantation, Gothenburg, 1987 (abstr)

Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, Van Buren CT (1987) Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft and recipients exclusively followed at a single center for from one to five years. Transplantation 43: 197–204

Lancman I, Tejani A, Pomrantz A, Khawar M, Chen C (1987) Nephrotoxicity of cyclosporine A (CSA) and cyclosporine G (CSG) in a rat model. Kidney Int 31: 461

Lorber ML, Van Buren CT, Flechner SM, Williams C, Kahan BD (1987) Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients. Transplantation 43: 35–40

Masri MA, Naiem M, Daar AS (1987) Age and dose dependence of cyclosporine G nephrotoxicity in BALB/c mice. Transplant Proc 19: 1212–1213

Mihatsch MJ, Thiel G, Spichtin HP, Oberholzer M, Brunner FP, Harder F, Oliviere B, Bremer R, Ryffel B, Stöcklin E, Torhorst J, Gudat F, Zollinger HU, Lörtscher R (1983) Morphological findings in kidney transplant after treatment with cyclosporine. Transplant Proc 15: 605–619

Ogunnaike HO, Starkey TD, Baldwin JC, Billingham ME, Porter KA, Jamieson SW (1987) Comparison of Nva2-cyclosporine and cyclosporine A in primate cardiac transplantation. Transplantation 43: 13–17

Otsu I, Kitano N, Taminato T, Fujiya H, Mozawa M (1987) Cyclosporine A toxicity for vascularised pancreatic transplantation in the rat. Transplant Proc 19: 1252–1256

Ryffel B (1986) Toxicology-experimental studies. In: Borel JF (ed) Cyclosporine. (Progress in allergy, vol 38) Karger, Basel, pp 181–197

Ryffel B, Siegl H, Petric R, Muller AM, Hauser R, Mihatsch MJ (1986) Nephrotoxicity of cyclosporine in spontaneously hypertensive rats: effects on blood pressure and vascular lesions. Clin Nephrol [Suppl 1] 25: S 193-S 198

Stiller CR, Dupre J, Gent M, Jenner MR, Keonwn TA, Laupacis A, Martell R, Rodger NW, Graffenried B, Wolfe DMJ (1984) Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 23: 1362–1367

Thiru S, Maher ER, Hamilton DV, Evans DB, Calne RY (1983) Tubular changes in renal transplant recipients on cyclosporine. Transplant Proc 15: 630–635

Traber R, Loosli HR, Hofman H, Kuhn M, Von Wartburg A (1983) Isolierung und Strukturermittlung der neuen Cyclosporine E, F, H und I. Helv Chir Acta 65: 1655–1677

Verani R (1986) Cyclosporine nephrotoxicity in the Fisher rat. Clin Nephrol [Suppl 1] 26: S9-S13

Wenger RM (1986) Synthesis of cyclosporine and analogues: structural and confirmational requirements for immunosuppressive activity. In: Borel JF (ed) Cyclosporine. (Progress in allergy, vol 38) Karger, Basel, pp 46–64

Zaghloul I, Burckart GJ, Starzl TE, Todo S, Ptacheinski RJ, Venkataramanan R (1986) Cyclosporine G analysis and monitoring by high pressure liquid chromatography. Transplant Proc 18: 771–773

Thông tin
Thông tin xuất bản

Transplant International

Tập 1

13-18

Thông tin tác giả